BACKGROUND: Left ventricular (LV) hypertrophy and LV diastolic dysfunction, which are common cardiac changes in hypertensive patients, are modified by several nonhemodynamic (eg, genetic, neurohumoral, and metabolic) factors. However, the influence of serum lipids on these LV changes has not been sufficiently studied. Although low high-density lipoprotein (HDL) cholesterol is well known to be a major risk factor for coronary heart disease, it is unclear whether HDL cholesterol plays a role in hypertensive heart disease. METHODS: In 274 patients with treated essential hypertension, two-dimensional and Doppler echocardiography were performed, and LV mass, ratio of peak velocity of atrial filling to early diastolic filling (A to E ratio [A/E]), and deceleration time of the E-wave were evaluated. The relationship of dyslipidemia, especially low HDL cholesterol, to LV hypertrophy and diastolic function was investigated in these patients. RESULTS: In a univariate regression analysis, HDL cholesterol was inversely associated with LV mass, A/E, and deceleration time. The association of HDL cholesterol with LV diastolic function was observed in both men and women. Its association with LV mass was gender-dependent, being significant only in women. Triglycerides were weakly correlated with LV mass and A/E, but total and low-density lipoprotein cholesterol had no correlations with these indices. In a multiple regression analysis, only low HDL cholesterol among several lipid levels was an independent predictor of both LV mass and LV diastolic dysfunction. CONCLUSIONS: Our findings suggest that low HDL cholesterol may unfavorably modify LV structure and diastolic function in patients with treated essential hypertension.
BACKGROUND:Left ventricular (LV) hypertrophy and LV diastolic dysfunction, which are common cardiac changes in hypertensivepatients, are modified by several nonhemodynamic (eg, genetic, neurohumoral, and metabolic) factors. However, the influence of serum lipids on these LV changes has not been sufficiently studied. Although low high-density lipoprotein (HDL) cholesterol is well known to be a major risk factor for coronary heart disease, it is unclear whether HDL cholesterol plays a role in hypertensive heart disease. METHODS: In 274 patients with treated essential hypertension, two-dimensional and Doppler echocardiography were performed, and LV mass, ratio of peak velocity of atrial filling to early diastolic filling (A to E ratio [A/E]), and deceleration time of the E-wave were evaluated. The relationship of dyslipidemia, especially low HDL cholesterol, to LV hypertrophy and diastolic function was investigated in these patients. RESULTS: In a univariate regression analysis, HDL cholesterol was inversely associated with LV mass, A/E, and deceleration time. The association of HDL cholesterol with LV diastolic function was observed in both men and women. Its association with LV mass was gender-dependent, being significant only in women. Triglycerides were weakly correlated with LV mass and A/E, but total and low-density lipoprotein cholesterol had no correlations with these indices. In a multiple regression analysis, only low HDL cholesterol among several lipid levels was an independent predictor of both LV mass and LV diastolic dysfunction. CONCLUSIONS: Our findings suggest that low HDL cholesterol may unfavorably modify LV structure and diastolic function in patients with treated essential hypertension.
Authors: Piotr Dobrowolski; Aleksander Prejbisz; Anna Klisiewicz; Elżbieta Florczak; Justyna Rybicka; Andrzej Januszewicz; Piotr Hoffman Journal: Hypertens Res Date: 2015-03-19 Impact factor: 3.872
Authors: Raghava S Velagaleti; Michael J Pencina; Ramachandran S Vasan; Emelia J Benjamin; Joseph M Massaro; Karol Pencina; Daniel Levy Journal: Am J Cardiol Date: 2010-03-11 Impact factor: 2.778
Authors: Kirsten Bibbins-Domingo; Mark J Pletcher; Feng Lin; Eric Vittinghoff; Julius M Gardin; Alexander Arynchyn; Cora E Lewis; O Dale Williams; Stephen B Hulley Journal: N Engl J Med Date: 2009-03-19 Impact factor: 91.245
Authors: Raghava S Velagaleti; Joseph Massaro; Ramachandran S Vasan; Sander J Robins; William B Kannel; Daniel Levy Journal: Circulation Date: 2009-11-23 Impact factor: 29.690
Authors: Nir Ayalon; Deepa M Gopal; Deirdre M Mooney; Juliana S Simonetti; Jason R Grossman; Aeshita Dwivedi; Courtney Donohue; Alejandro J Perez; Jill Downing; Noyan Gokce; Edward J Miller; Chang-Seng Liang; Caroline M Apovian; Wilson S Colucci; Jennifer E Ho Journal: Am J Cardiol Date: 2014-07-01 Impact factor: 2.778
Authors: Fang Zhao; Rong Yang; Rusitanmujiang Maimaitiaili; Jiamin Tang; Song Zhao; Jing Xiong; Jiadela Teliewubai; Chen Chi; Jacques Blacher; Jue Li; Yawei Xu; Yan Jiang; Yi Zhang; Weiming Li Journal: Front Cardiovasc Med Date: 2021-07-09